We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

76 hedge funds and large institutions have $365M invested in Celldex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,008% more capital invested

Capital invested by funds: $7.15M → $365M (+$358M)

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

388% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 8

185% more call options, than puts

Call options by funds: $13.2M | Put options by funds: $4.61M

69% more funds holding

Funds holding: 45 → 76 (+31)

54.61% more ownership

Funds ownership: 22.58% → 77.19% (+55%)

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

Holders
76
Holders Change
+31
Holders Change %
+68.89%
% of All Funds
1.56%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
39
Increased
12
Reduced
10
Closed
8
Calls
$13.2M
Puts
$4.61M
Net Calls
+$8.55M
Net Calls Change
+$8.38M

Top Buyers

1
BI
BVF Inc
California
+$12.1M
2
RI
RTW Investments
New York
+$11.6M
3
LGM
Logos Global Management
California
+$8.86M
4
RG
Redmile Group
California
+$8.86M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.76M

Top Sellers

1
MG
Meditor Group
Bermuda
-$993K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$313K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$174K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$85.5K
5
BCM
Bridgeway Capital Management
Texas
-$83K
Name Holding Trade Value Shares
Change 		Change in
Stake
Skandinaviska Enskilda Banken (SEB)
51
Skandinaviska Enskilda Banken (SEB)
Sweden
$43K +$14.8K +3,333 New
PAM
52
Panagora Asset Management
Massachusetts
$23K – – –
LC
53
Lindbrook Capital
California
$21K +$7.17K +1,618 New
VFA
54
Valeo Financial Advisors
Indiana
$20K +$3.7K +834 +125%
Osaic Holdings
55
Osaic Holdings
Arizona
$17K +$1.63K +367 +38%
GWM
56
Geneos Wealth Management
Colorado
$16K – – –
FDCDDQ
57
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.8K – – –
UBS Group
58
UBS Group
Switzerland
$7K -$1.36K -307 -34%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$3K -$5.12K -1,155 -81%
Wells Fargo
60
Wells Fargo
California
$3K -$350 -79 -24%
MLFP
61
MPS Loria Financial Planners
Illinois
$2K +$589 +133 New
PAG
62
Private Advisor Group
New Jersey
$2K +$594 +134 New
Bank of America
63
Bank of America
North Carolina
$1K -$199 -45 -46%
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$1K – – –
JP Morgan Chase
65
JP Morgan Chase
New York
$1K – – –
Northwestern Mutual Wealth Management
66
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
KFS
67
Kelly Financial Services
Massachusetts
$598 – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$39 -$93 -21 -88%
BCM
69
Bridgeway Capital Management
Texas
– -$83K -50,200 Closed
CS
70
Credit Suisse
Switzerland
– -$58K -35,317 Closed
Group One Trading
71
Group One Trading
Illinois
– -$44.6K -10,065 Closed
TRCT
72
Tower Research Capital (TRC)
New York
– -$8K -4,843 Closed
Victory Capital Management
73
Victory Capital Management
Texas
– -$8K -4,400 Closed
Barclays
74
Barclays
United Kingdom
– +$9 +2 New
BCM
75
Bourgeon Capital Management
Connecticut
– +$13 +3 New
1 2
3
4

CLDX Hedge Fund Activity: Q2 2020 in Review

76 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q2 2020, worth a combined $365M — up 5,008% from $7.15M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLDX positions and 8 closed out — a net gain of 31 holders — while 12 added to existing stakes and 10 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $12.1M. The largest seller was Meditor Group, cutting an estimated $993K.

  • 76 institutional investors held Celldex Therapeutics (CLDX) as of Q2 2020, up from 45 in Q1 2020.
  • Funds reported $365M of Celldex Therapeutics stock for Q2 2020, up 5,008% quarter-over-quarter.
  • 39 funds opened new Celldex Therapeutics positions in Q2 2020 and 8 closed out, a net change of +31 holders.
  • The largest Celldex Therapeutics buyer in Q2 2020 was BVF Inc, an estimated $12.1M added.
  • The largest Celldex Therapeutics seller in Q2 2020 was Meditor Group, an estimated $993K sold.

Based on aggregated 13F filings for Q2 2020.